Literature DB >> 18653246

HIV-1-infected and/or immune-activated macrophages regulate astrocyte CXCL8 production through IL-1beta and TNF-alpha: involvement of mitogen-activated protein kinases and protein kinase R.

Jialin C Zheng1, Yunlong Huang, Kang Tang, Min Cui, Doug Niemann, Alicia Lopez, Susan Morgello, Shengdi Chen.   

Abstract

Monocyte infiltration is an important pathogenic event in human immunodeficiency virus type one (HIV-1) associated dementia (HAD). CXCL8 (Interleukin 8, IL-8), a CXC chemokine that elicits chemotaxis of neutrophils, has recently been found to recruit monocytes or synergistically enhance CCL2-mediated monocyte migration. In this report, we demonstrate CXCL8 levels in the cerebrospinal fluid of HAD patients are higher than HIV-1 seropositive patients without neurological impairment. The underlying mechanisms regulating CXCL8 production during disease are not completely understood. We investigated the role of HIV-1-infected and immune-competent macrophages, the principal target cell and mediator of neuronal injury in HAD, in regulating astrocyte CXCL8 production. Immune-activated and HIV-1-infected human monocyte-derived-macrophages (MDM) conditioned media (MCM) induced production of CXCL8 by human astrocytes. This CXCL8 production was dependent on MDM IL-1beta and TNF-alpha production following viral and immune activation. CXCL8 production was reduced by inhibitors for mitogen-activated protein kinases (MAPKs), including p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinases (ERK1/2). Moreover, prolonged IL-1beta or TNF-alpha treatment activated double-stranded RNA-activated protein kinase (PKR). Inhibition of PKR prevented elevated CXCL8 production in astrocytes. We conclude that IL-1beta and TNF-alpha, produced from HIV-1-infected and immune-competent macrophages, are critical in astrocyte CXCL8 production. Multiple protein kinases, including p38, JNK, ERK1/2, and PKR, participate in the inflammatory response of astrocytes. These observations will help to identify effective therapeutic strategies to reduce high-levels of CXCL8-mediated CNS inflammation during HAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653246      PMCID: PMC2596956          DOI: 10.1016/j.jneuroim.2008.06.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  52 in total

1.  AIDS dementia complex with generalized myoclonus.

Authors:  J Maher; S Choudhri; W Halliday; C Power; A Nath
Journal:  Mov Disord       Date:  1997-07       Impact factor: 10.338

2.  Variable progression of HIV-associated dementia.

Authors:  F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

Review 3.  Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms.

Authors:  A Nath; J Geiger
Journal:  Prog Neurobiol       Date:  1998-01       Impact factor: 11.685

4.  Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.

Authors:  J M Strizki; A V Albright; H Sheng; M O'Connor; L Perrin; F González-Scarano
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 5.  Quantitative neuropathologic assessment of HIV-1 encephalitis.

Authors:  C A Wiley
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

6.  An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis.

Authors:  Y Persidsky; M Buttini; J Limoges; P Bock; H E Gendelman
Journal:  J Neurovirol       Date:  1997-12       Impact factor: 2.643

Review 7.  The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.

Authors:  J Zheng; H E Gendelman
Journal:  Curr Opin Neurol       Date:  1997-08       Impact factor: 5.710

8.  Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects.

Authors:  M Denis; E Ghadirian
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205

9.  Chemokines and receptors in HIV encephalitis.

Authors:  V J Sanders; C A Pittman; M G White; G Wang; C A Wiley; C L Achim
Journal:  AIDS       Date:  1998-06-18       Impact factor: 4.177

10.  Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.

Authors:  J D Glass; H Fedor; S L Wesselingh; J C McArthur
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

View more
  38 in total

1.  Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes.

Authors:  Nicholas A Floreani; Travis J Rump; P M Abdul Muneer; Saleena Alikunju; Brenda M Morsey; Michael R Brodie; Yuri Persidsky; James Haorah
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-09       Impact factor: 4.147

Review 2.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

3.  Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.

Authors:  Jenna M Puccini; Daniel F Marker; Tim Fitzgerald; Justin Barbieri; Christopher S Kim; Patrick Miller-Rhodes; Shao-Ming Lu; Stephen Dewhurst; Harris A Gelbard
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 4.  Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.

Authors:  Kathryn E Medders; Marcus Kaul
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-01       Impact factor: 4.147

5.  Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.

Authors:  Neha Vartak-Sharma; Benjamin B Gelman; Chaitanya Joshi; Kathleen Borgamann; Anuja Ghorpade
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 6.  Neuropharmacologic Approaches to Restore the Brain's Microenvironment.

Authors:  Weizhe Li; Hsin-I Tong; Santhi Gorantla; Larisa Y Poluektova; Howard E Gendelman; Yuanan Lu
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

Review 7.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

8.  Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.

Authors:  Rajnish S Dave; Kamel Khalili
Journal:  J Cell Biochem       Date:  2010-07-01       Impact factor: 4.429

9.  SOLUBLE CD40 LIGAND IN DEMENTIA.

Authors:  B Giunta; K P Figueroa; T Town; J Tan
Journal:  Drugs Future       Date:  2009-04-01       Impact factor: 0.148

Review 10.  Strategies to target non-T-cell HIV reservoirs.

Authors:  Jonah B Sacha; Lishomwa C Ndhlovu
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.